ENTX
Entera Bio Ltd
NASDAQ: ENTX · HEALTHCARE · BIOTECHNOLOGY
$1.19
+6.25% today
Updated 2026-04-30
Market cap
$60.98M
P/E ratio
—
P/S ratio
1,452.00x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Entera Bio Ltd (ENTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.50M | $-3.14M | $-4.53M | $-9.80M | $-8.92M | $-10.56M | $-9.06M | $-12.50M | $-7.31M | $-6.82M | $-7.37M |
| Capital expenditures | $54000.00 | $41000.00 | $51000.00 | $68000.00 | $40000.00 | $53000.00 | $17000.00 | $46999.00 | $17000.00 | $3000.00 | $107000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $366000.00 | $1.49M | $4.88M | $1.23M | $1.48M | $901000.00 | $1.86M | $2.25M | $1.69M | $2.56M | $2.75M |
| Free cash flow | $-3.55M | $-3.18M | $-4.58M | $-9.86M | $-8.96M | $-10.61M | $-9.08M | $-12.55M | $-7.33M | $-6.82M | $-7.48M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |